Manifestations of paediatric Leishmania infantum infections in Malta

Travel Medicine and Infectious Disease

Volumn 9, Issue 1, 2011, Pages 37-46

  Pace, David ^a   Williams, Thomas N ^b   Grochowska, Alicja ^a   Betts, Alexandra ^a   Attard Montalto, Simon ^a   Boffa, Michael J ^c   Vella, Cecil ^a  

^a MATER DEI HOSPITAL   (Malta)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Sir Paul Boffa Hospital   (Malta)

Author keywords

Leishmania infantum; Malta; Paediatric leishmaniasis; Phlebotomine sand fly

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; LIPOSOME; STIBOGLUCONATE SODIUM;

ADOLESCENT; AMASTIGOTE; ARTICLE; BONE MARROW BIOPSY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEISHMANIA INFANTUM; LEISHMANIASIS; MALE; MALTA; PALLOR; PANCYTOPENIA; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DISEASE; SKIN INFECTION; SKIN LEISHMANIASIS; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MALTA; PHLEBOTOMUS;

EID: 79951811327     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2010.11.005     Document Type: Article

References (52)

1. Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2008;2(10):e313.
2. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol 1996 Sep-Oct;14(5):417-23.
3. World Health Organization. The global burden of disease: 2004 update. Geneva: WHO. Available from, http://www.who.int/healthinfo/global-burden- disease/2004-report-update/en/index.html; 2008 [accessed 05.03.10].
4. World Health Organization Regional Office for Europe, 1998-2007 for Southern European countries: Cyprus, France, Greece, Italy, Malta, Portugal, Spain and Turkey. Available at http://data.euro.who.int/cisid. [accessed 19.02.10].
5. Malik AN, John L, Bruceson AD, Lockwood DN. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerg Infect Dis 2006 Aug;12(8):1257-9.
6. Malta in figures 2009. Valletta: National Statistics Office. Available from, www.nso.gov.mt; 2009 [accessed 08.11.10].
7. Léger N, Marchais R, Madulo-Leblond R, Pesson G, Kristensen A, Ferté A, et al. Les phlébotomes impliqués dans la transmission des leishmanioses dans l'île de Gozo (Malte). Ann Parasitol Hum Comp 1991;66:33-41 [Article in French].
8. Gradoni L, Gramiccia M, Léger N, Pesson B, Madulo-Leblond G, Killick-Kendrick R, et al. Isoenzyme characterization of Leishmania from man, dog and sandflies in the Maltese islands. Trans R Soc Trop Med Hyg 1991 Mar-Apr;85(2):217-9.
9. Headington CE, Barbara CH, Lambson BE, Hart DT, Barker DC. Diagnosis of leishmaniasis in Maltese dogs with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg 2002 Apr; 96(Suppl. 1):S195-7.
10. Gramiccia M, Gradoni L, Troiani M. HIV-Leishmania co-infections in Italy. isoenzyme characterization of leishmania causing visceral leishmaniasis in HIV patients. Trans R Soc Trop Med Hyg 1992 Mar-Apr;86(2):161-3.
11. Vella Briffa D. Cutaneous leishmaniasis in the MalteseIslands. Br J Dermatol 1985;113(3):370-1.
12. Crétien A. Kala-azar infantile a Malte. note preliminaire. Arch Inst Pasteur Tunis 1910;2:49-51.
13. Department for Health Promotion and Disease Prevention, Malta. Infectious Disease Prevention and Control Unit (IDCU). Data for visceral and cutaneous leishmaniasis from 1946-1979; 1990-2008, personal communication.
14. Department of Health Information, Malta. Data for visceral and cutaneous leishmaniasis from 1980-1989, personal communication.
15. Grech V, Mizzi J, Mangion M, Vella C. Visceral leishmaniasis in Malta-an 18 year paediatric, population based study. Arch Dis Child 2000 May;82(5):381-5. (Pubitemid 30307766)
16. Department of Health Information, Malta. Malta National Mortality Register; 1991-2007.
17. Aquilina A. HSE Laboratories, Malta, personal communication.
18. Agius-Ferrante TJ. Infantile visceral leishmaniasis in the MalteseIslands. Br Med J 1955 Sep 10;2(4940):654-6.
19. Killick-Kendrick R. The biology and control of phlebotomine sand flies. Clin Dermatol 1999 May-Jun;17(3):279-89. (Pubitemid 29497892)
20. Ready PD. Leishmania manipulates sandfly feeding to enhance its transmission. Trends Parasitol 2008 Apr;24(4):151-3.
21. Leishmania-Spot IF. Package insert. Biomerieux, Marcyl'Etoile, France.
22. Leishmania ELISA IgG + IgM. Package insert. Vircell, Granada, Spain. Available from www.vircell.com. [accessed 19.10.10].
23. Cascio A, Colomba C, Antinori S, Orobello M, Paterson D, Titone L. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. Eur J Clin Microbiol Infect Dis 2002 Apr;21(4):277-82. (Pubitemid 34507872)
24. Maltezou HC, Siafas C, Mavrikou M, Spyridis P, Stavrinadis C, Karpathios T, et al. Visceral leishmaniasis during childhood in southern Greece. Clin Infect Dis 2000 Nov;31(5):1139-43. (Pubitemid 32295440)
25. Minodier P, Piarroux R, Garnier JM, Unal D, Perrimond H, Dumon H. Pediatric visceral leishmaniasis in southern France. Pediatr Infect Dis J 1998 Aug;17(8):701-4. (Pubitemid 28388159)
26. Dursun O, Erişir S, Yeşilipek A. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years. Turk J Pediatr 2009 Jan-Feb;51(1):1-5.
27. Petrela R, Kuneshka L, Foto E, Zavalani F, Gradoni L. Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1210 consecutive hospitalized patients (1995-2009). PLoS Negl Trop Dis 2010 Sep 7;4(9):pii: e814.
28. Campino S, Kwiatkowski D, Dessein A. Mendelian and complex genetics of susceptibility and resistance to parasitic infections. Semin Immunol 2006 Dec;18(6):411-22. (Pubitemid 44511887)
29. Riera C, Fisa R, López-Chejade P, Serra T, Girona E, Jiménez M, et al. Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion 2008 Jul; 48(7):1383-9.
30. Bhattacharya SK, Sur D, Karbwang J. Childhood visceral leishmaniasis. Indian J Med Res 2006 Mar;123(3):353-6. (Pubitemid 43905575)
31. Antinori S, Calattini S, Longhi E, Bestetti G, Piolini R, Magni C, et al. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis 2007 Jun 15; 44(12):1602-10. (Pubitemid 46871507)
32. Motazedian M, Fakhar M, Motazedian MH, Hatam G, Mikaeili F. A urine-based polymerase chain reaction method for the diagnosis of visceral leishmaniasis in immunocompetent patients. Diagn Microbiol Infect Dis 2008 Feb;60(2):151-4.
33. Kohanteb J, Ardehali S. Cross-reaction of sera from patients with various infectious diseases with leishmania infantum. Med Princ Pract 2005 Mar-Apr;14(2):79-82. (Pubitemid 40529217)
34. Louzir H, Belal-Kacemi L, Sassi A, Laouini D, Ben Ismail R, Dellagi K. Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with mediterranean visceral leishmaniasis. the leishmania study group. Clin Exp Immunol 1994 Mar;95(3):479-84.
35. Argov S, Jaffe CL, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients infected with leishmania. Clin Exp Immunol 1989 May;76(2):190-7. (Pubitemid 19150387)
36. Sakkas LI, Boulbou M, Kyriakou D, Makri I, Sinani C, Germenis A, et al. Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem 2008 Jan; 41(1-2):65-8. (Pubitemid 350216833)
37. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A metaanalysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. Br Med J 2006 Oct 7;333(7571):723.
38. Sarkari B, Chance M, Hommel M. Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen. Acta Trop 2002 Jun;82(3):339-48. (Pubitemid 34556971)
39. Reithinger R, Dujardin JC. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 2007 Jan;45(1):21-5. (Pubitemid 46106401)
40. World Health Organization. Control of the leishmaniases. report of a WHO expert committee. World Health Organ Tech Rep Ser 1990;793:1-158.
41. Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, et al. Drug regimens for visceral leishmaniasis in Mediterranean countries. Trop Med Int Health 2008 Oct;13(10):1272-6.
42. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 2007 Jun 21;356(25):2571-81. (Pubitemid 46961002)
43. Palumbo E. Oral miltefosine treatment in children with visceral leishmaniasis: a brief review. Braz J Infect Dis 2008 Feb;12(1):2-4.
44. Asilian A, Jalayer T, Nilforooshzadeh M, Ghassemi RL, Peto R, Wayling S, et al. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull World Health Organ 2003;81(5):353-9. (Pubitemid 36644261)
45. Layegh P, Pezeshkpoor F, Soruri AH, Naviafar P, Moghiman T. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children. Am J Trop Med Hyg 2009 Feb;80(2):172-5.
46. Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell RJ, Davies CR, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 2005 Apr 15;40(8):1148-55. (Pubitemid 40490240)
47. González U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev 2009 Apr 15;(2). CD004834.
48. Miró G, Cardoso L, Pennisi MG, Oliva G, Baneth G. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two. Trends Parasitol 2008 Aug;24(8):371-7.
49. Gavgani AS, Hodjati MH, Mohite H, Davies CR. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002 Aug 3;360(9330):374-9.
50. Dantas-Torres F. Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine. Vet Parasitol 2006 Oct 10;141(1-2):1-8. (Pubitemid 44363138)
51. Cachia EA, Fenech FF. A review of kal-azar in Malta from 1947-1962. Trans R Soc Trop Med Hyg 1964 May;58:234-41.
52. Croft AM, Taylor NA, Rodenhurst KE. Sandflies and leishmaniasis. Lancet 2006;367(9505):112.